Insider · CIK 0001760673

Sassi Nir

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001760673

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-22	INDPIndaptus Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+26.8K sh	$2.03	+$54.3K	26,758
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−1,250 sh	$0.07	−$88.75	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−1,125 sh	$0.07	−$79.875	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−2,500 sh	$0.07	−$177.5	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−500 sh	$0.07	−$35.5	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−500 sh	$0.07	−$35.5	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−41 sh	$0.07	−$2.911	0
2025-04-10	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−1,125 sh	$0.07	−$79.875	0
2024-10-09	INDPIndaptus Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2024-01-22	INDPIndaptus Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2023-01-18	INDPIndaptus Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2022-02-25	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000
2021-08-04	INDPIndaptus Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+35K sh	—	—	35,000
2020-09-16	Intec Pharma Ltd.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2020-02-17	Intec Pharma Ltd.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+90K sh	—	—	90,000
2019-09-13	Intec Pharma Ltd.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2019-01-22	Intec Pharma Ltd.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+90K sh	—	—	90,000

Recent filings

Accepted (ET)
Dec 294
Sassi Nir0001493152-25-029356
SEC(opens sec.gov)
Apr 114
Sassi Nir0001641172-25-003826
SEC(opens sec.gov)
Oct 104
Sassi Nir0001493152-24-040729
SEC(opens sec.gov)
Jan 234
Sassi Nir0001493152-24-003445
SEC(opens sec.gov)
Jan 204
Sassi Nir0001493152-23-002020
SEC(opens sec.gov)
Feb 284
Sassi Nir0001493152-22-005611
SEC(opens sec.gov)
Aug 64
Sassi Nir0001493152-21-018906
SEC(opens sec.gov)
Sep 184
Sassi Nir0001213900-20-027396
SEC(opens sec.gov)
Feb 194
Sassi Nir0001213900-20-004343
SEC(opens sec.gov)
Sep 164
Sassi Nir0001213900-19-018237
SEC(opens sec.gov)
Jan 234
Sassi Nir0001213900-19-001104
SEC(opens sec.gov)

Companies

Address

C/O INDAPTUS THERAPEUTICS, INC 3 COLUMBUS CIRCLE, 15TH FLOOR

NEW YORK, NY, 10019